Envista Holdings Corporation (NYSE: NVST) today announced results for the fourth quarter and full year 2023. For the quarter ended December 31, 2023, reported sales were $645.6 million. Core sales...

Envista Holdings Corporation (NYSE: NVST) ("Envista") announced today that it has joined Women in DSO® as a Platinum Industry partner. Women in DSO advances and empowers female professionals,...

Envista Holdings Corporation (NYSE: NVST) ("Envista") will report financial results for its fourth quarter 2023 on Wednesday, February 7, 2024. Envista will discuss these results on a conference...

Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced that the company will participate in the J.P. Morgan Healthcare Conference on Monday, January 8, 2024 at 3:00 – 3:40 PM PST....

Envista Holdings Corporation (NYSE: NVST) today announced the expansion of its leadership team, with the recent appointments of Robert Befidi as President, Diagnostics; Suraj Satpathy as Chief...